Analysts Set Acadia Healthcare Company, Inc. (NASDAQ:ACHC) Target Price at $26.04

Acadia Healthcare Company, Inc. (NASDAQ:ACHC) has received a consensus rating of “Hold” from the sixteen analysts that are covering the stock, Marketbeat reports. Two research analysts have rated the stock with a sell recommendation, seven have issued a hold recommendation, six have given a buy recommendation and one has issued a strong buy recommendation on the company. The average 1-year price target among brokerages that have issued a report on the stock in the last year is $26.0385.

A number of analysts recently weighed in on ACHC shares. TD Cowen lifted their price target on Acadia Healthcare from $24.00 to $30.00 and gave the company a “buy” rating in a research note on Tuesday, April 28th. Zacks Research upgraded shares of Acadia Healthcare from a “strong sell” rating to a “hold” rating in a report on Thursday, March 5th. Leerink Partners increased their price objective on Acadia Healthcare from $14.00 to $22.00 and gave the company a “market perform” rating in a research note on Thursday, February 26th. Barclays raised their price objective on Acadia Healthcare from $20.00 to $25.00 and gave the stock an “equal weight” rating in a report on Thursday, April 30th. Finally, Cantor Fitzgerald increased their target price on Acadia Healthcare from $20.00 to $30.00 and gave the stock a “neutral” rating in a research report on Friday, May 1st.

Acadia Healthcare Stock Performance

Shares of ACHC stock opened at $25.81 on Monday. The company has a market cap of $2.37 billion, a P/E ratio of -2.11, a PEG ratio of 9.01 and a beta of 0.73. The firm has a fifty day moving average price of $25.28 and a 200 day moving average price of $19.26. The company has a current ratio of 1.71, a quick ratio of 1.71 and a debt-to-equity ratio of 1.27. Acadia Healthcare has a 12 month low of $11.43 and a 12 month high of $30.20.

Acadia Healthcare (NASDAQ:ACHC) last released its quarterly earnings data on Wednesday, April 29th. The company reported $0.37 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.28 by $0.09. Acadia Healthcare had a positive return on equity of 7.09% and a negative net margin of 32.84%.The business had revenue of $828.80 million during the quarter, compared to analysts’ expectations of $823.51 million. During the same period in the prior year, the firm posted $0.40 EPS. The business’s quarterly revenue was up 7.6% compared to the same quarter last year. Acadia Healthcare has set its Q2 2026 guidance at 0.300-0.400 EPS. Sell-side analysts predict that Acadia Healthcare will post 1.49 earnings per share for the current fiscal year.

Institutional Investors Weigh In On Acadia Healthcare

Institutional investors have recently bought and sold shares of the stock. EverSource Wealth Advisors LLC boosted its holdings in shares of Acadia Healthcare by 54.8% in the 2nd quarter. EverSource Wealth Advisors LLC now owns 1,404 shares of the company’s stock valued at $32,000 after purchasing an additional 497 shares during the last quarter. Federated Hermes Inc. raised its holdings in shares of Acadia Healthcare by 1.5% in the 4th quarter. Federated Hermes Inc. now owns 43,913 shares of the company’s stock worth $623,000 after purchasing an additional 668 shares during the period. Price T Rowe Associates Inc. MD lifted its stake in shares of Acadia Healthcare by 0.9% during the fourth quarter. Price T Rowe Associates Inc. MD now owns 74,907 shares of the company’s stock worth $1,063,000 after purchasing an additional 696 shares in the last quarter. Public Employees Retirement System of Ohio boosted its position in shares of Acadia Healthcare by 2.8% in the third quarter. Public Employees Retirement System of Ohio now owns 31,335 shares of the company’s stock worth $776,000 after buying an additional 867 shares during the period. Finally, Treasurer of the State of North Carolina grew its stake in shares of Acadia Healthcare by 2.1% in the second quarter. Treasurer of the State of North Carolina now owns 42,502 shares of the company’s stock valued at $964,000 after buying an additional 867 shares in the last quarter.

Key Headlines Impacting Acadia Healthcare

Here are the key news stories impacting Acadia Healthcare this week:

• Positive Sentiment: Zacks Research raised several forward EPS estimates for Acadia Healthcare, including Q1 2027 to $0.26, Q2 2027 to $0.45, Q3 2027 to $0.54, Q4 2027 to $0.38, FY2027 to $1.63, and FY2028 to $1.76, signaling better earnings visibility ahead.
• Positive Sentiment: A separate report said Acadia Healthcare’s price target was increased by 18.24% to $28.82, which suggests analysts see more upside than before. Article Title
• Neutral Sentiment: Zacks Research kept its overall rating at Hold, so while estimates improved, the firm is not yet calling the stock a strong buy.
• Negative Sentiment: Not all revisions were positive: Zacks lowered FY2026 EPS to $1.46 from $1.48 and cut Q2 2026 EPS to $0.35 from $0.49, which may temper near-term enthusiasm.

About Acadia Healthcare

Acadia Healthcare Company, Inc (NASDAQ: ACHC) is a publicly traded provider of behavioral healthcare services headquartered in Franklin, Tennessee. Founded in 2005, the company has grown through organic expansion and strategic acquisitions to establish itself as a leading specialist in mental health and addiction treatment across the United States.

Acadia operates a diversified network of inpatient psychiatric hospitals, residential treatment centers, outpatient clinics and intensive outpatient programs.